| Pratyusha Reddy Katta, MD | |
|
175 Madison Ave, Mount Holly, NJ 08060-2099 | |
| (609) 914-6000 | |
| Not Available |
| Full Name | Pratyusha Reddy Katta |
|---|---|
| Gender | Female |
| Speciality | Hospitalist |
| Location | 175 Madison Ave, Mount Holly, New Jersey |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699013045 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | MD452969 (Pennsylvania) | Secondary |
| 208M00000X | Hospitalist | 25MA09342900 (New Jersey) | Primary |
| Entity Name | Children's Health Care Associates Of New Jersey Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427152917 PECOS PAC ID: 1052219110 Enrollment ID: O20031229000053 |
News Archive
EnzymeRx, LLC (www.enzymerx.com), a clinical-stage biotechnology company, announced that it has launched its first clinical study of Uricase-PEG 20. Subjects have begun enrolling in a phase 1 safety, pharmacokinetic and pharmacodynamic study of single intravenous doses of Uricase-PEG 20.
Talk to anyone for very long about how to improve health care in the U.S. and you eventually hear something along the lines of: "We have to start paying physicians for getting and keeping people healthy instead of for doing as many procedures and tests as possible" (Hobson, 6/9).
Researchers at Yale School of Medicine have identified a key link between stem cell factors that fuel ovarian cancer's growth and patient prognosis. The study, which paves the way for developing novel targeted ovarian cancer therapies, is published online in the current issue of Cell Cycle.
Laphonza Butler, Co-Trustee of SEIU ULTCW released the following statement regarding Governor Schwarzenegger's recommended cuts to the state's In-Home Supportive Services program in his FY 10-11 proposed budget today.
ARMGO Pharma, Inc., a biopharmaceutical company developing innovative small molecule drugs known as "Rycals™," which act on the ryanodine receptor calcium-release channel (RyR), announced that a study published today in the prestigious scientific journal Cell reveals the underlying role of calcium leak through the RyR as an important contributor to stress-induced cognitive dysfunction.
› Verified 5 days ago
| Entity Name | Nemours New Jersey Physician Practice Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265874713 PECOS PAC ID: 4486871159 Enrollment ID: O20140805000413 |
News Archive
EnzymeRx, LLC (www.enzymerx.com), a clinical-stage biotechnology company, announced that it has launched its first clinical study of Uricase-PEG 20. Subjects have begun enrolling in a phase 1 safety, pharmacokinetic and pharmacodynamic study of single intravenous doses of Uricase-PEG 20.
Talk to anyone for very long about how to improve health care in the U.S. and you eventually hear something along the lines of: "We have to start paying physicians for getting and keeping people healthy instead of for doing as many procedures and tests as possible" (Hobson, 6/9).
Researchers at Yale School of Medicine have identified a key link between stem cell factors that fuel ovarian cancer's growth and patient prognosis. The study, which paves the way for developing novel targeted ovarian cancer therapies, is published online in the current issue of Cell Cycle.
Laphonza Butler, Co-Trustee of SEIU ULTCW released the following statement regarding Governor Schwarzenegger's recommended cuts to the state's In-Home Supportive Services program in his FY 10-11 proposed budget today.
ARMGO Pharma, Inc., a biopharmaceutical company developing innovative small molecule drugs known as "Rycals™," which act on the ryanodine receptor calcium-release channel (RyR), announced that a study published today in the prestigious scientific journal Cell reveals the underlying role of calcium leak through the RyR as an important contributor to stress-induced cognitive dysfunction.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Pratyusha Reddy Katta, MD 8 Madeira Ct, Moorestown, NJ 08057-3144 Ph: (732) 857-7742 | Pratyusha Reddy Katta, MD 175 Madison Ave, Mount Holly, NJ 08060-2099 Ph: (609) 914-6000 |
News Archive
EnzymeRx, LLC (www.enzymerx.com), a clinical-stage biotechnology company, announced that it has launched its first clinical study of Uricase-PEG 20. Subjects have begun enrolling in a phase 1 safety, pharmacokinetic and pharmacodynamic study of single intravenous doses of Uricase-PEG 20.
Talk to anyone for very long about how to improve health care in the U.S. and you eventually hear something along the lines of: "We have to start paying physicians for getting and keeping people healthy instead of for doing as many procedures and tests as possible" (Hobson, 6/9).
Researchers at Yale School of Medicine have identified a key link between stem cell factors that fuel ovarian cancer's growth and patient prognosis. The study, which paves the way for developing novel targeted ovarian cancer therapies, is published online in the current issue of Cell Cycle.
Laphonza Butler, Co-Trustee of SEIU ULTCW released the following statement regarding Governor Schwarzenegger's recommended cuts to the state's In-Home Supportive Services program in his FY 10-11 proposed budget today.
ARMGO Pharma, Inc., a biopharmaceutical company developing innovative small molecule drugs known as "Rycals™," which act on the ryanodine receptor calcium-release channel (RyR), announced that a study published today in the prestigious scientific journal Cell reveals the underlying role of calcium leak through the RyR as an important contributor to stress-induced cognitive dysfunction.
› Verified 5 days ago
Dr. Jubril Oyekanmi Oyeyemi, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 175 Madison Ave, Mount Holly, NJ 08060 Phone: 609-914-6180 Fax: 609-914-6182 | |
Erik Delue, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 175 Madison Ave, Mount Holly, NJ 08060 Phone: 609-914-6180 Fax: 609-914-6182 | |
Dr. Zaheer Husain, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 175 Madison Ave, Mount Holly, NJ 08060 Phone: 609-914-6180 Fax: 609-914-6182 | |
Dr. Pierre Rigens Valeus, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 175 Madison Ave, Mount Holly, NJ 08060 Phone: 609-267-0700 | |
Dr. Swati Hasmukh Patel, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 175 Madison Ave, Hospitalist Group, Mount Holly, NJ 08060 Phone: 609-267-0700 | |
Dr. James Ward, DO Hospitalist Medicare: Medicare Enrolled Practice Location: 175 Madison Ave, Mount Holly, NJ 08060 Phone: 609-914-6000 Fax: 609-914-6182 | |
Brian Peng, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 175 Madison Ave, Mount Holly, NJ 08060 Phone: 609-914-6180 Fax: 609-914-6182 |